BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12492955)

  • 1. Histologically benign but telomerase positive adrenal pheochromocytoma.
    Hirano Y; Nobata S; Takahashi H; Kageyama S; Sudoko H; Ushiyama T; Suzuki K; Fujita K
    Int J Urol; 2002 Dec; 9(12):697-9. PubMed ID: 12492955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of telomerase activity in malignant pheochromocytoma.
    Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
    Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
    Thompson LD
    Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in the differentiation of benign and malignant adrenal tumors.
    Teng L; Tucker O; Malchoff C; Vaughan ED; Jacobson J; Fahey TJ
    Surgery; 1998 Dec; 124(6):1123-7. PubMed ID: 9854593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity as an indicator of potentially malignant adrenal tumors.
    Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; Tsuda F
    Cancer; 1998 Aug; 83(4):772-6. PubMed ID: 9708944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal oncocytic pheochromocytoma.
    Li M; Wenig BM
    Am J Surg Pathol; 2000 Nov; 24(11):1552-7. PubMed ID: 11075859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
    Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of Sipple syndrome whose bilateral pheochromocytomas were resected separately after a 3-year interval].
    Kimura T; Ikemoto I; Furuta N; Ohishi Y
    Hinyokika Kiyo; 2000 Apr; 46(4):251-3. PubMed ID: 10845156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse proportion in composite pheochromocytoma-ganglioneuroma may induce varied clinical symptom: comparison of two cases.
    Zhang BY; Zhao M; Li B; Zhang JM
    Int J Clin Exp Pathol; 2015; 8(11):15369-74. PubMed ID: 26823896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.
    McNicol AM
    Endocr Pathol; 2006; 17(4):329-36. PubMed ID: 17525481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in benign and malignant adrenal tumors.
    Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
    Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for pheochromocytoma: A 20-year experience of a single institution.
    Aggeli C; Nixon AM; Parianos C; Vletsis G; Papanastasiou L; Markou A; Kounadi T; Piaditis G; Zografos GN
    Hormones (Athens); 2017 Oct; 16(4):388-395. PubMed ID: 29518759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique association of pheochromocytoma with contralateral nonfunctioning adrenal cortical adenoma.
    Morimoto S; Sasaki S; Moriguchi J; Miki S; Kawa T; Nakamura K; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):117-21. PubMed ID: 9504459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant pheochromocytoma: diagnosis and treatment].
    Yang D; Li S; Li X; Liu S; Wang H; Han W; Hao J
    Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):104-5. PubMed ID: 11829794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology teach and tell: pheochromocytoma.
    Collins GL; Wallis-Crespo MC; Gillbert-Barness E
    Fetal Pediatr Pathol; 2004; 23(2-3):199-203. PubMed ID: 15768865
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral adrenal tumors from different histology: case report and literature review.
    Zhang Y; Li H; Xiao J; Zhou Y; Zhou Z; Tong A
    Cell Biochem Biophys; 2015 Jan; 71(1):425-9. PubMed ID: 25164113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of adrenal pheochromocytoma with contralateral adrenocortical adenoma].
    Yotsuyanagi S; Fuse H; Koshida K; Uchibayashi T; Namiki M
    Hinyokika Kiyo; 2001 Feb; 47(2):89-93. PubMed ID: 11280892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features.
    Kinoshita H; Ogawa O; Mishina M; Oka H; Okumura K; Yamabe H; Terachi T; Yoshida O
    Urol Res; 1998; 26(1):29-32. PubMed ID: 9537693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.